| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9646465 | Schizophrenia Research | 2005 | 7 Pages |
Abstract
Long-term treatment with clozapine was associated with three-fold overall reduction of risk of suicidal behaviors. However, available findings are quantitatively inconsistent, well-designed studies remain rare, and the only randomized trial did not find reduced risk of completed suicide. Additional randomized comparisons among modern treatments for psychotic disorders are required to clarify their impact on mortality.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
John Hennen, Ross J. Baldessarini,